Infliximab in severe refractory Kawasaki disease

被引：0
|
作者：
Zanon, G. [1 ]
Martini, G. [1 ]
Schiavo, B. [1 ]
Maschietto, N. [1 ]
Milanesi, O. [1 ]
Zulian, F. [1 ]
机构：
[1] Univ Padua, Dept Pediat, Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [21] Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients
    Akira Hachiya
    Norimoto Kobayashi
    Satoshi Matsuzaki
    Yusuke Takeuchi
    Yohei Akazawa
    Tomonari Shigemura
    Noriko Motoki
    Junya Masumoto
    Kazunaga Agematsu
    Clinical Rheumatology, 2018, 37 : 1937 - 1943
  • [22] Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients
    Hachiya, Akira
    Kobayashi, Norimoto
    Matsuzaki, Satoshi
    Takeuchi, Yusuke
    Akazawa, Yohei
    Shigemura, Tomonari
    Motoki, Noriko
    Masumoto, Junya
    Agematsu, Kazunaga
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1937 - 1943
  • [23] Infliximab as an alternative therapy for refractory adult onset Kawasaki disease A case report
    Kawaguchi, Takeshi
    Rikitake, Yuki
    Tsuruda, Toshihiro
    Kawata, Chihiro
    Rikitake, Mao
    Iwao, Kosho
    Aizawa, Ayako
    Kariya, Yumi
    Matsuda, Motohiro
    Miyauchi, Syunichi
    Umekita, Kunihiko
    Takajo, Ichiro
    Okayama, Akihiko
    MEDICINE, 2018, 97 (40)
  • [24] Infliximab for the treatment of Kawasaki disease
    Matsubara, Tomoyo
    PEDIATRICS INTERNATIONAL, 2018, 60 (09) : 775 - 775
  • [25] Incomplete and atypical Kawasaki disease in a young infant: Severe, recalcitrant disease responsive to infliximab
    O'Connor, Matthew J.
    Saulsbury, Frank T.
    CLINICAL PEDIATRICS, 2007, 46 (04) : 345 - 348
  • [26] Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease
    Ansai, Hideto
    Masuda, Hiroshi
    Nakao, Hiro
    Nishimura, Nao
    Kubota, Mitsuru
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [27] Successful Infliximab Treatment for Refractory Kawasaki Disease in a Neonate: A Case Report and Literature Review
    Toyokawa, Tomiko
    Kogaki, Shigetoyo
    Takahashi, Kunihiko
    Kayatani, Futoshi
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2021, 60
  • [28] S100 Proteins Could Not Be Suppressed by Infliximab Treatment in Refractory Kawasaki Disease
    Hirono, Keiichi
    Kemmotsu, Yasushi
    Saito, Kazuyoshi
    Ibuki, Keijirou
    Kanegane, Hirokazu
    Ichida, Fukiko
    Saji, Tsutomu
    Miyawaki, Toshio
    CIRCULATION RESEARCH, 2009, 105 (07) : E22 - E23
  • [29] Refractory Kawasaki disease
    Freeman, AF
    Shulman, ST
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (05) : 463 - 464
  • [30] Rapid response of severe refractory metastatic Crohn's disease to infliximab
    Miller, AM
    Elliott, PR
    Fink, R
    Connell, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (08) : 940 - 942
12345